Neuropsychological, electrophysiological, and neuroimaging biomarkers for REM behavior disorder
- 11 July 2019
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 19 (11) , 1069-1087
Abstract
Introduction: Rapid Eye Movement (REM) sleep Behavior disorder (RBD) is a REM sleep parasomnia characterized by dream enacting behaviors allowed by the loss of physiological atonia during REM sleep. This disorder is recognized as a prodromal stage of neurodegenerative disease, in particular Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB). Therefore, a timely identification of biomarkers able to predict an early conversion into neurodegeneration is of utmost importance. Areas covered: In this review, the authors provide updated evidence regarding the presence of neuropsychological, electrophysiological and neuroimaging markers in isolated RBD (iRBD) patients when the neurodegeneration is yet to come. Expert opinion: Cognitive profile of iRBD patients is characterized by the presence of impairment in visuospatial abilities and executive function that is observed in α-synucleinopathies. However, longitudinal studies showed that impaired executive functions, rather than visuospatial abilities, augmented conversion risk. Cortical slowdown during wake and REM sleep suggest the presence of an ongoing neurodegenerative process paralleled by cognitive decline. Neuroimaging findings showed that impairment nigrostriatal dopaminergic system might be a good marker to identify those patients at higher risk of short-term conversion. In spite of a growing body of evidence the identification of biomarkers still represents a critical issue in iRBD.Keywords
Funding Information
- not funded
This publication has 139 references indexed in Scilit:
- The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s diseaseBrain, 2013
- Short latency afferent inhibition differs among the subtypes of mild cognitive impairmentJournal of Neural Transmission, 2011
- Functional network disruption in the degenerative dementiasThe Lancet Neurology, 2011
- Quantitative EEG as a predictive biomarker for Parkinson disease dementiaNeurology, 2011
- Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohortSleep Medicine, 2011
- Sleep State SwitchingNeuron, 2010
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- Toward discovery science of human brain functionProceedings of the National Academy of Sciences, 2010
- Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological studyBrain, 2009
- MEG resting state functional connectivity in Parkinson’s disease related dementiaJournal of Neural Transmission, 2008